PPARG and pulmonary emphysema: PPARγ inactivation has previously been reported to cause inflammation-triggered cell growth and emphysema in lal−/− mice, and treatment with the PPARγ ligand 9-HODE significantly rescued lal−/− pulmonary inflammation and aberrant gene expression [14].